Uquifa
Uquifa is a manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates, catering to the pharmaceutical and animal health industries worldwide. The company operates three manufacturing facilities, with two located in Spain and one in Mexico, all adhering to current Good Manufacturing Practices (cGMP) and having received approvals from prominent pharmaceutical companies and regulatory bodies, including the US FDA. Uquifa offers a diverse portfolio of APIs and other specialty products, in addition to Contract Development and Manufacturing Organization (CDMO) services, positioning itself as a significant player in the global pharmaceutical supply chain.
1 past transactions
SONEAS Chemicals
Acquisition in 2018
SONEAS Chemicals Ltd., established in 1996 and headquartered in Budapest, Hungary, specializes in chemistry services for pharmaceutical development. The company offers custom synthesis from laboratory to pilot plant scale, route selection, process optimization, analytical services, and more. Its capabilities include optical resolutions, high temperature reactions, and specialized chemical transformations like cyanations. With a team of over 140 employees, SONEAS operates two research sites and an 8,000 sq m facility housing process R&D, kilo lab, and a cGMP-approved pilot plant. Additionally, it offers commercial-scale manufacturing for pharmaceutical intermediates and APIs at its 65,000 sq m site. The company's client base includes prominent pharmaceutical companies such as Chinoin, Ogeda, Eisai, and Leo Pharma. Since November 2018, SONEAS has been a subsidiary of Union Quimico Farmacéutica, S.A.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.